Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Stigmatization and quality of life in people with alopecia are influenced by gender and sociodemographics, suggesting a need for better support.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

Skin, hair, and nail changes can help detect eating disorders early.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

People with AB blood type may be more likely to get melasma.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

More personalized and effective treatments for androgenetic alopecia are needed.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

A community dermatology event in Delhi showed a high need for follow-up and awareness about skin conditions.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Patients with non-scarring hair loss often have emotional disorders.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Melanocytes are destroyed by factors needed for melanin production, causing vitiligo and gray hair.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Vitiligo patients often have other health issues, especially thyroid disorders.

Skin grafting can help repigment vitiligo, but it's less effective for widespread cases due to the Koebner phenomenon.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Vitiligo is a skin condition causing white patches, likely due to an autoimmune issue.